Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Malignant Melanoma

  Free Subscription


1 Am J Dermatopathol
1 Am J Ophthalmol
1 Anticancer Res
1 Cancer
1 Cancer Lett
1 Clin Cancer Res
1 Eur J Dermatol
1 J Immunother
1 J Invest Dermatol
1 J Surg Oncol
2 Lancet Oncol
1 Oncogene
1 Ophthalmology
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Dermatopathol

  1. PARRA-MEDINA R, Morales SD
    Cutaneous Perivascular Epithelioid Cell Tumor of Gynecologic Origin Metastatic to Skin, Lung, Stomach, and Brain.
    Am J Dermatopathol. 2016.
    PubMed     Text format    

    Am J Ophthalmol

  2. BELLERIVE C, Aziz HA, Bena J, Wilkinson A, et al
    Local Failure after Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors and Management.
    Am J Ophthalmol. 2017 Feb 2. pii: S0002-9394(17)30048.
    PubMed     Text format     Abstract available

    Anticancer Res

  3. RYU SH, Heo SH, Park EY, Choi KC, et al
    Selumetinib Inhibits Melanoma Metastasis to Mouse Liver via Suppression of EMT-targeted Genes.
    Anticancer Res. 2017;37:607-614.
    PubMed     Text format     Abstract available


  4. Some Europeans with melanoma lack access to new, lifesaving drugs.
    Cancer. 2017;123:543-544.
    PubMed     Text format    

    Cancer Lett

  5. DE SOUZA LM, Robertson BM, Robertson GP
    Future of Circulating Tumor Cells in the Melanoma Clinical and Research Laboratory Settings.
    Cancer Lett. 2017 Feb 2. pii: S0304-3835(17)30064.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  6. BARONE A, Hazarika M, Theoret MR, Mishra-Kalyani P, et al
    FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma.
    Clin Cancer Res. 2017 Feb 8. pii: clincanres.0664.2016.
    PubMed     Text format     Abstract available

    Eur J Dermatol

  7. THIERAUF J, Veit JA, Hess J, Treiber N, et al
    Checkpoint inhibition for advanced mucosal melanoma.
    Eur J Dermatol. 2017 Feb 3. doi: 10.1684/ejd.2016.2949.
    PubMed     Text format     Abstract available

    J Immunother

  8. BRICOUT M, Petre A, Amini-Adle M, Bezza W, et al
    Vogt-Koyanagi-Harada-like Syndrome Complicating Pembrolizumab Treatment for Metastatic Melanoma.
    J Immunother. 2017;40:77-82.
    PubMed     Text format     Abstract available

    J Invest Dermatol

  9. ZHOU Y, Tripathi SV, Rosman I, Ma J, et al
    Noninvasive Determination of Melanoma Depth using a Handheld Photoacoustic Probe.
    J Invest Dermatol. 2017 Feb 2. pii: S0022-202X(17)30104.
    PubMed     Text format    

    J Surg Oncol

  10. CHANG TN, Lee CH, Lai CH, Wu CW, et al
    Profunda artery perforator flap for isolated vulvar defect reconstruction after oncological resection.
    J Surg Oncol. 2016;113:828-34.
    PubMed     Text format     Abstract available

    Lancet Oncol

  11. BRUNDAGE M, Hanna T
    Adjuvant ipilimumab for stage III melanoma: the patient voice.
    Lancet Oncol. 2017 Feb 2. pii: S1470-2045(17)30003.
    PubMed     Text format    

  12. COENS C, Suciu S, Chiarion-Sileni V, Grob JJ, et al
    Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.
    Lancet Oncol. 2017 Feb 2. pii: S1470-2045(17)30015.
    PubMed     Text format     Abstract available


  13. LUO S, Li Y, Ma R, Liu J, et al
    Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  14. SHIELDS CL, Say EA, Hasanreisoglu M, Saktanasate J, et al
    Cytogenetic Abnormalities in Uveal Melanoma Based on Tumor Features and Size in 1059 Patients: The 2016 W. Richard Green Lecture.
    Ophthalmology. 2017 Jan 31. pii: S0161-6420(16)31846.
    PubMed     Text format     Abstract available

    PLoS One

  15. KONSTANTAKOU EG, Velentzas AD, Anagnostopoulos AK, Litou ZI, et al
    Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets.
    PLoS One. 2017;12:e0171512.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.